automation, integration and better accuracy than microscopy or culture methods, its 1 0 3 sensitivity for some bacilli clinical specimen is still inadequate. Furthermore, the cost 1 0 4 of cartridges, instrumentation and maintenance of Xpert MTB/RIF system make it 1 0 5
impossible to set-up in many high TB burden countries, which further limited its 1 0 6 usefulness 9, 10 . In recent years, isothermal amplification assays using loop mediated polymerase amplification (RPA) [13] [14] [15] have been extensively applied in the field of 1 1 0 molecular diagnosis including pulmonary TB diagnosis [16] [17] [18] . Especially, the RPA applied for pathogen diagnosis [20] [21] [22] , liquid biopsy 23 , and SNP/genotyping 24 . However, 1 2 0 the synthesis of long oligonucleotide probes with multiple modifications is cost, and 1 2 1 different probes with the same amplified region may also affect the efficiency of RPA. For evaluation the sensitivity of Cas12a/gRNA for MTB fluorescence assay, a series 2 6 8 of gradient dilution concentration of IS1081 plasmid from 8960 pM to 44.8 fM were 2 6 9 prepared with 1 µL volume as RPA template. Meanwhile, no-MTB DNA was used as 2 7 0 negative control and all of them were performed in three replicates. Total DNA mass 2 7 1 for the assay was determined following formula: M/5-7×(4.38×10 6 × 660) = µg/µL. M 2 7 2 is concentration of IS1081 plasmid, 5-7 is number of copies of IS1081 per MTB The practical performance evaluation of the MTB detection assay was carried out via Cpf1-CRISPR-DT online software and range from 0.7061 to 0.97 was selected after 3 0 5
excluding that of less than 0.6, and nine gRNAs were remained. In the end, we 3 0 6
selected one that the score of target efficiency was 0.7061 based on unconspicuous 3 0 7
secondary structure under reaction temperature and specificity of gRNA spacer for observed IS1081 plasmid and ssDNA reporters were cleaved almost at the same time. These results suggested that the cis-and trans-cleavage activity ability of purified 3 2 5
Cas12a protein is quite high and Cas12a/gRNA system for MTB detection is feasible. In order to simplify operation to achieve "one-pot" detection pattern and improve factors for Cas12a/gRNA trans-cleavage fluorescence assay, and the assay obtained higher fluorescence intensity under optimized conditions using the same concentration 3 3 8 of target. Therefore, these conditions were used in the following experiments for MTB To evaluate the ability of MTB-Cas12a trans-cleavage fluorescence assay, a series of 3 4 3 gradient concentration of diluted IS1081 plasmids and genome of pathogens that may 3 4 4
infect human respiratory tract were tested. For the sensitivity of MTB-Cas12a gradually with the decrease of concentration of IS1081 plasmid, and the limit of To assess the specificity of the MTB-Cas12a fluorescence assay, genome of the gold standard culture method were tested. Consequently, the fluorescence assay and specificity of 100% (53/53) ( Table 2 ). Its performance was nearly similar to 3 7 2 culture method except that one of culture-positive sample was failed to be detected 3 7 3 whose fluorescence intensity was lower 1.5 times than that of negative result. Maybe this one failed to be detected by the assay due to the low concentration of genome 3 7 5 and/or it was degraded in storage or during deliver process. Especially, the major 3 7 6
reason could be that the MTB target for guide RNA recognition exist mutation 3 7 7
resulting in none-complete hybridization, namely "turn-off" effect. As far as we can 3 7 8 infer, it may be resolved by the modification of gRNA covering mutation site, such as r  e  c  o  m  b  i  n  a  s  e  p  o  l  y  m  e  r  a  s  e  a  m  p  l  i  f  i  c  a  t  i  o  n  .  P  L  o  S  O  n  e  2  0  1  4  ,  9  :  e  1  0  3  0  9  1  .  4  9  5  1  9  .  D  a  h  e  r  R  K  ,  S  t  e  w  a  r  t  G  ,  B  o  i  s  s  i  n  o  t  M  ,  B  o  u  d  r  e  a  u  D  K  ,  B  e  r  g  e  r  o  n  M  G  :  I  n  f  l  u  e  n  c  e  o  f  s  eu  e  n  c  e  4  9  6  m  i  s  m  a  t  c  h  e  s  o  n  t  h  e  s  p  e  c  i  f  i  c  i  t  y  o  f  r  e  c  o  m  b  i  n  a  s  e  p  o  l  y  m  e  r  a  s  e  a  m  p  l  i  f  i  c  a  t  i  o  n  t  e  c  h  n  o  l  o  g  y  .  4  9  7  M  o  l  e  c  u  l  a  r  &  C  e  l  l  u  l  a  r  P  r  o  b  e  s  2  0  1  5  ,  2  9  :  1  1  6  -1  2 3  4  .  G  o  o  t  e  n  b  e  r  g  J  S  ,  A  b  u  d  a  y  y  e  h  O  O  ,  K  e  l  l  n  e  r  M  J  ,  J  o  u  n  g  J  ,  C  o  l  l  i  n  s  J  J  ,  Z  h  a  n  g  F  :  M  u  l  t  i  p  l  e  x  e  d  a  n  d  5  3  9  p  o  r  t  a  b  l  e  n  u  c  l  e  i  c  a  c  i  d  d  e  t  e  c  t  i  o  n  p  l  a  t  f  o  r  m  w  i  t  h  C  a  s  1  3  ,  C  a  s  1  2  a  ,  a  n  d  C  s  m  6  .  S  c  i  e  n  c  e  2  0  1  8  ,  5  4  0  3  6  0  :  4  3  9  -4  4  4  .  5  4  1  3  5  .  H  a  r  r  i  n  g  t  o  n  L  B  ,  B  u  r  s  t  e  i  n  D  ,  C  h  e  n  J  S  ,  P  a  e  z  -E  s  p  i  n  o  D  ,  M  a  E  ,  W  i  t  t  e  I  P  ,  C  o  f  s  k  y  J  C  ,  K  y  r  p  i  d  e  s  N  C  ,  5  4 
